AZN EQUITY ALERT: Labaton Sucharow Announces Filing of Securities Class Action Lawsuit Against AstraZeneca PLC – NASDAQ: AZNBusiness Wire • 01/27/21
Production of AstraZeneca's COVID-19 vaccine has been suspended after a 'suspicious package' was sent to one of its largest plantsBusiness Insider • 01/27/21
AstraZeneca Hits Back At EU Accusation It's Backtracking On Its Covid-19 Vaccine ContractForbes • 01/27/21
AZN EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against AstraZeneca PLC – AZNBusiness Wire • 01/27/21
AstraZeneca defends slow supplies to the EU, but says it ordered 3 months later than the U.K.CNBC • 01/27/21
Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against AstraZeneca plcBusiness Wire • 01/27/21
Reports that AstraZeneca's vaccine is less effective in older people appear to be based on botched statistics, the German government saysBusiness Insider • 01/26/21
AstraZeneca Battles Supply Chain Issues, Denies Claims Its Covid-19 Vaccine Is Largely Ineffective In SeniorsForbes • 01/26/21
AstraZeneca denies its vaccine is less efficient in the elderly; battles with EU over suppliesCNBC • 01/26/21
Top Coronavirus Vaccine Makers Will Earn Up to $23 Billion in Revenue This Year, Says New AnalysisThe Motley Fool • 01/22/21
AstaZeneca, Foot Locker, PayPal, Tesla, Yeti and More of Friday Afternoon's Analyst Calls24/7 Wall Street • 01/15/21
AVEO Oncology Announces Results from Phase 1b Portion of DEDUCTIVE Study of Tivozanib (FOTIVDA®) in Combination with IMFINZI® (durvalumab) in Previously Untreated Metastatic Hepatocellular CarcinomaBusiness Wire • 01/15/21